0001493152-24-022029.txt : 20240530
0001493152-24-022029.hdr.sgml : 20240530
20240530180006
ACCESSION NUMBER: 0001493152-24-022029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240528
FILED AS OF DATE: 20240530
DATE AS OF CHANGE: 20240530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aminov Erez
CENTRAL INDEX KEY: 0001986112
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41765
FILM NUMBER: 241006954
MAIL ADDRESS:
STREET 1: C/O MIRA PHARMACEUTICALS, INC.
STREET 2: 900 WEST PLATT STREET, SUITE 200
CITY: TAMPA
STATE: FL
ZIP: 33606-2173
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MIRA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001904286
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 853354547
STATE OF INCORPORATION: FL
BUSINESS ADDRESS:
STREET 1: 1200 BRICKELL AVENUE
STREET 2: SUITE 1950 #1183
CITY: MIAMI
STATE: FL
ZIP: 33131
BUSINESS PHONE: 813-369-5150
MAIL ADDRESS:
STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350
CITY: TAMPA
STATE: FL
ZIP: 33606
FORMER COMPANY:
FORMER CONFORMED NAME: Mira1a Therapeutics, Inc.
DATE OF NAME CHANGE: 20220112
4
1
ownership.xml
X0508
4
2024-05-28
0
0001904286
MIRA PHARMACEUTICALS, INC.
MIRA
0001986112
Aminov Erez
C/O MIRA PHARMACEUTICALS, INC.
1200 BRICKELL AVE. SUITE 1950 #1183
MIAMI
FL
33131
1
1
0
0
Chief Executive Officer
0
Incentive Stock Options (right to buy)
0.84
2024-05-28
4
A
0
379000
0
A
2034-05-28
Common Stock
379000
629000
D
The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on May 28, 2024.
The stock options were issued to the Reporting Person on May 28, 2024, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). The stock options vested in full and became exercisable immediately upon issuance on the grant date, May 28, 2024.
Represents 50,000 stock options that were issued to the Reporting Person on April 28, 2023 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $5.00 each, (ii) 150,000 stock options that were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which vested in full on August 17, 2023 at an exercise price of $6.50 each, (iii) 50,000 stock options that were issued to the Reporting Person on August 17, 2023 that vested in full and became exercisable on April 28, 2024, pursuant to a grant under the Issuer's Plan at an exercise price of $6.50 each, and (iv) 379,000 stock options that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $0.84 each.
/s/ Michelle Yanez, Attorney-in-Fact for Erez Aminov
2024-05-30